We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.88B
AUM Growth
+$149M
Cap. Flow
-$5.76M
Cap. Flow %
-0.08%
Top 10 Hldgs %
10.94%
Holding
341
New
18
Increased
129
Reduced
136
Closed
6

Top Sells

Rank Stock Value
1
LQDT icon
Liquidity Services
LQDT
+$29.4M
2
RES icon
RPC Inc
RES
+$20.1M
3
COHR icon
Coherent
COHR
+$20.1M
4
VRTS icon
Virtus Investment Partners
VRTS
+$19.5M
5
AGN
Allergan Inc
AGN
+$16.7M

Sector Composition

Rank Sector Weight
1 Financials 16.43%
2 Technology 15.98%
3 Industrials 15.12%
4 Healthcare 11.3%
5 Consumer Discretionary 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWAV
201
DELISTED
The WhiteWave Foods Company
WWAV
$5.35M 0.08%
165,185
-40,906
-20% -$1.22M
WSM icon
202
Williams-Sonoma
WSM
$26.3B
$5.18M 0.08%
144,374
+800
+0.6% +$26.3K
AGN
203
DELISTED
Allergan Inc
AGN
$5.17M 0.08%
30,575
-107,048
-78% -$16.7M
JCI icon
204
Johnson Controls International
JCI
$85B
$4.99M 0.07%
95,500
COO icon
205
Cooper Companies
COO
$14B
$4.95M 0.07%
145,980
-800
-0.5% -$26.4K
VWO icon
206
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$4.91M 0.07%
113,938
-308
-0.3% -$13K
VCSH icon
207
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$4.66M 0.07%
57,968
+6,050
+12% +$485K
TJX icon
208
TJX Companies
TJX
$172B
$4.51M 0.07%
169,894
+32,408
+24% +$925K
NVS icon
209
Novartis
NVS
$285B
$4.35M 0.06%
53,635
+18,330
+52% +$1.44M
GE icon
210
GE Aerospace
GE
$354B
$4.14M 0.06%
32,861
-728
-2% -$92.6K
BMS
211
DELISTED
Bemis
BMS
$3.83M 0.06%
94,166
+33,675
+56% +$1.37M
CVD
212
DELISTED
COVANCE INC.
CVD
$3.67M 0.05%
42,946
-485
-1% -$43.2K
MDLZ icon
213
Mondelez International
MDLZ
$77.4B
$3.66M 0.05%
97,287
+950
+1% +$34.7K
MRK icon
214
Merck
MRK
$307B
$3.59M 0.05%
65,062
+17,659
+37% +$963K
KMB icon
215
Kimberly-Clark
KMB
$36B
$3.48M 0.05%
32,586
+12,985
+66% +$1.38M
ES icon
216
Eversource Energy
ES
$27.8B
$3.37M 0.05%
71,199
+20,152
+39% +$924K
ORLY icon
217
O'Reilly Automotive
ORLY
$70.1B
$2.81M 0.04%
279,375
-18,375
-6% -$181K
CNI icon
218
Canadian National Railway
CNI
$76.9B
$2.76M 0.04%
42,400
+1,600
+4% +$95.2K
SAP icon
219
SAP
SAP
$185B
$2.75M 0.04%
35,737
+3,850
+12% +$299K
T icon
220
AT&T
T
$153B
$2.71M 0.04%
101,417
+33,132
+49% +$888K
VGK icon
221
Vanguard FTSE Europe ETF
VGK
$29.7B
$2.63M 0.04%
43,900
+1,000
+2% +$60.2K
PFE icon
222
Pfizer
PFE
$141B
$2.61M 0.04%
92,590
LPLA icon
223
LPL Financial
LPLA
$26.2B
$2.57M 0.04%
51,763
-42
-0.1% -$2.04K
KO icon
224
Coca-Cola
KO
$353B
$2.48M 0.04%
58,665
-527
-0.9% -$21.4K
EXPD icon
225
Expeditors International
EXPD
$23.2B
$2.48M 0.04%
56,125
-10,200
-15% -$439K

Similar funds

Boston Trust Walden's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Trust Walden held 341 positions worth $6.88B, up 2.2% from $6.73B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Boston Trust Walden's Q2 2014 filing shows 18 new, 129 increased, 136 reduced and 6 closed positions. Its largest new stake was Ubiquiti: 989,903 shares worth $44.7M. The largest sale was Liquidity Services, an estimated $29.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Boston Trust Walden's largest Q2 2014 buy was Ubiquiti: 989,903 shares worth $44.7M.
  • Boston Trust Walden added most to Express Scripts Holding Company in Q2 2014, an estimated $19.5M increase.
  • Boston Trust Walden's biggest Q2 2014 reduction was RPC Inc, cutting an estimated $20.1M.
  • Boston Trust Walden fully exited Liquidity Services in Q2 2014, selling an estimated $29.4M.
  • Boston Trust Walden's ten largest holdings make up 11% of its $6.88B portfolio in Q2 2014.
  • Boston Trust Walden opened 18 new positions and closed 6 in Q2 2014.
  • Boston Trust Walden's portfolio value rose 2.2% quarter-over-quarter to $6.88B.

Based on Boston Trust Walden's 13F filing for Q2 2014, filed 1 Aug 2014.